Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

33.84 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 46.09311.59138.33426.60738.46134.329.48548.50987.94323.53121.48522.714-9.6214.1177.386-0.2081.911-0.027-38.62-36.44-31.9-20.616-63.021
Depreciation & Amortization 5.9686.0526.1246.1256.1066.0646.0646.0686.0636.0555.1994.764.6724.7294.6794.3831.9672.0041.8831.9451.0530.1230.089
Deferred Income Tax -4.83-14.279-3.4771.123-6.907-4.193-3.442-4.264-81.67900026.1460001.5250.43823.7850000
Stock Based Compensation 11.04811.08810.3948.8637.9917.6487.2037.267.0077.2784.6284.1984.2533.9073.3012.8231.0730.4290.3688.8050.4080.370.326
Change In Working Capital 11.704-14.514-20.32731.6446.728-7.0793.742-32.00535.446-4.022-3.5255.2584.123-5.3-3.45-0.4441.7651.616-14.565-1.5525.9321.9921.92
Accounts Receivables 1.655-3.438-5.579-6.876-3.452-11.2372.1650.325-5.243-11.689-3.29-1.637-2.011-7.58-1.439-5.851-1.087-3.931-7.053-4.2552.07300
Change In Inventory -1.2720.214-0.494-0.276-0.233-0.7640.207-0.3970.3080.389-0.1650.3730.146-0.546-0.582-1.512-0.228-0.212-0.783-0.172-0.91600
Change In Accounts Payables -12.1516.141-2.5866.196-0.0240.1492.628-6.2633.388-0.2435.903-3.1782.173-2.3851.835-6.7917.274-2.778-1.509-2.5935.040.6411.81
Other Working Capital 23.472-17.431-11.66832.610.4374.773-1.258-25.6736.9937.521-5.9739.73.8155.211-3.26413.71-4.1948.537-5.225.468-0.2651.3510.11
Other Non Cash Items 0.51862.95431.3942.30310.7210.323-0.4931.110.4250.8891.0650.6030.850.6170.6143.4930.5970.3720.4473.2551.0540.7350.091
Operating Cash Flow 70.50142.61731.14176.66563.137.06342.55926.67855.20533.73128.85237.53330.42418.0712.5310.0478.8384.832-26.702-23.987-23.453-17.401-10.595
Investing Activities:
Investments In Property Plant And Equipment -0.003-0.632-0.005-0.1070-0.205040.172-0.086-0.041-40.045100.298-0.093-0.201-100.004-20-0.0020-77.036-0.03-0.051-50.032
Acquisitions Net 0-33.0690-44.53307.56600-0.87200-10000000000000
Purchases Of Investments -23.287-21.211-25.106-21.613-33.009-25.071-47.776-55.092-33.231-22.4060000000000000
Sales Maturities Of Investments 24.03525.55618.92522.62232.19617.50545.9868.1970.87200000000000000
Other Investing Activites 0-25.5-6.1817.566-0.813-7.566-1.79-40.1720.872-22.406-4010000-100-2000-7700-50
Investing Cash Flow 0.745-54.856-6.186-36.065-0.813-7.771-1.79-46.895-32.445-22.447-40.045100.298-0.093-0.201-100.004-20-0.0020-77.036-0.03-0.051-50.032
Financing Activities:
Debt Repayment -3.75-3.75-3.75-3.75200-0.5-0.5-0.5-0.5-0.5-0.5-0.5-220000079.4152505520
Common Stock Issued -0.6890.5730.11600.2440.6753.909-0.4082.551.251.8837.57730.8340.6480.012147.6280000000
Common Stock Repurchased 0.269-0.2690-50-50-0.514000000000-0.1670-0.16700000
Dividends Paid 000-55.2600000000000-44.9070000000
Other Financing Activities 2.5750.3040.11655.487-255.0990.1613.9093.1582.551.251.8837.57221.6870.6480.012-1.156-11.0060-5.653-0.7948.868-2.525-1.784
Financing Cash Flow -1.175-3.446-3.634-53.523-55.099-0.3393.4092.6582.050.751.3837.072-0.3130.6480.012-1.156136.622-0.06773.76224.2148.86852.47518.216
Other Information:
Effect Of Forex Changes On Cash 00000000000-100.29800000000000
Net Change In Cash 70.341-15.68521.321-12.9237.18828.95344.178-17.55924.8112.034-9.8144.60530.01818.517-87.4626.891145.464.76347.06-76.81325.38535.023-42.411
Cash At End Of Period 387.637317.296332.981311.93324.853317.665288.712244.534262.093237.283225.249235.059190.454160.436141.919229.381222.4977.0372.26725.207102.0276.63541.612